Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2026 / June / Low Dose Atropine Beyond Refraction
Refractive Discussion Insights

Low-Dose Atropine: Beyond Refraction

Why clinical trial endpoints and dosing strategies should evolve in myopia control

By Hakan Kaymak, Carla Lança, Andrzej Grzybowski 6/24/2026 3 min read

Share

  • Full Article
  • Summary
  • Listen
  • Scorecard
  • Quiz
  • Poll
  • Top Institutions
Top Institutions in Ophthalmology

Ranking combines internal corpus citation frequency with web search results due to limited internal data for this topic.

  • #1

    Singapore National Eye Centre (SNEC) and Singapore Eye Research Institute (SERI)

    Singapore, Singapore

    SNEC/SERI designed and led the landmark ATOM trials that established low-dose atropine as a dose with favorable efficacy/tolerability profiles.

    Key Differentiators

    • Ophthalmology
  • #2

    The Chinese University of Hong Kong (CUHK), Department of Ophthalmology & Visual Sciences

    Hong Kong, China

    CUHK/HKEH’s LAMP series defined concentration-response and long-term outcomes for low-concentration atropine.

    Key Differentiators

    • Ophthalmology
  • #3

    Herbert Wertheim School of Optometry and Vision Science, University of California Berkeley

    Berkeley, California

    The institution is involved in research related to myopia and low-dose atropine.

    Key Differentiators

    • Optometry
  • #4

    University of Houston College of Optometry

    Houston, Texas

    The college is engaged in research and clinical trials related to myopia control.

    Key Differentiators

    • Optometry
  • #5

    Wills Eye Hospital

    Philadelphia, Pennsylvania

    Wills Eye Hospital is known for its clinical practice and research in ophthalmology.

    Key Differentiators

    • Ophthalmology

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: